46 related articles for article (PubMed ID: 12970333)
21. Malignant struma ovarii: recurrence and response to treatment monitored by thyroglobulin levels.
Rose PG; Arafah B; Abdul-Karim FW
Gynecol Oncol; 1998 Sep; 70(3):425-7. PubMed ID: 9790800
[TBL] [Abstract][Full Text] [Related]
22. Thyroglobulin measurements in the follow-up of patients with differentiated thyroid carcinoma: comparison with quantitative radioactive iodine uptake measurements and total body scans.
Bolk JH; Bussemaker JK; Nieuwenhuijzen Kruseman AC; De Vijlder JJ; Goslings BM
Neth J Med; 1985; 28(9):340-6. PubMed ID: 4047268
[No Abstract] [Full Text] [Related]
23. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.
Fugazzola L; Mihalich A; Persani L; Cerutti N; Reina M; Bonomi M; Ponti E; Mannavola D; Giammona E; Vannucchi G; di Blasio AM; Beck-Peccoz P
J Clin Endocrinol Metab; 2002 Jul; 87(7):3201-8. PubMed ID: 12107225
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
[TBL] [Abstract][Full Text] [Related]
25. Conservative management of thyroglobulin-positive, nonlocalizable thyroid carcinoma.
Frank RW; Middleton L; Stack BC; Spencer HJ; Riggs AT; Bodenner DL
Head Neck; 2014 Feb; 36(2):155-7. PubMed ID: 23728951
[TBL] [Abstract][Full Text] [Related]
26. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
27. [Thyroid carcinoma. A descriptive retrospective study].
Gonzalez CC; Yaniskowski ML; Wyse EP; Giovannini AA; Lopez MB; Wior ME
Medicina (B Aires); 2006; 66(6):526-32. PubMed ID: 17240623
[TBL] [Abstract][Full Text] [Related]
28. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients.
Pelizzo MR; Boschin IM; Toniato A; Piotto A; Bernante P; Pagetta C; Rampin L; Rubello D
Eur J Surg Oncol; 2006 Dec; 32(10):1144-8. PubMed ID: 16872798
[TBL] [Abstract][Full Text] [Related]
29. Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
Terris DJ
Head Neck; 2010 Jun; 32(6):698-9. PubMed ID: 20187017
[No Abstract] [Full Text] [Related]
30. Prevalence of the metabolic syndrome in the United States, 2003-2012.
Aguilar M; Bhuket T; Torres S; Liu B; Wong RJ
JAMA; 2015 May; 313(19):1973-4. PubMed ID: 25988468
[No Abstract] [Full Text] [Related]
31. Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy.
Ju Y; Wang L; Cheng F; Huang F; Chen X; Song Q; Xiao J; Zhu X; Jia H
BMC Endocr Disord; 2023 Jan; 23(1):19. PubMed ID: 36670396
[TBL] [Abstract][Full Text] [Related]
32. [Serum thyroglobulin in thyroid cancer and other thyroid diseases].
Demidchik EP; Kruglova NE; Minaĭlo TI; Gauptman AE; Koren' TA; Gedrevich ZE; Sevkovskiĭ IaI
Lab Delo; 1990; (7):16-8. PubMed ID: 1699058
[TBL] [Abstract][Full Text] [Related]
33. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.
Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF
J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907
[TBL] [Abstract][Full Text] [Related]
34. Rising thyroglobulin tumour marker during pregnancy in a thyroid cancer patient: no cause for alarm?
Murray JR; Williams GR; Harrington KJ; Newbold K; Nutting CM
Clin Endocrinol (Oxf); 2012 Jul; 77(1):155-7. PubMed ID: 22171652
[No Abstract] [Full Text] [Related]
35. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
Fatemi S; LoPresti JS
J Clin Endocrinol Metab; 2003 Sep; 88(9):4507-8; author reply 4508-10. PubMed ID: 12970333
[No Abstract] [Full Text] [Related]
36. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
Mazzaferri EL; Robbins RJ; Spencer CA; Braverman LE; Pacini F; Wartofsky L; Haugen BR; Sherman SI; Cooper DS; Braunstein GD; Lee S; Davies TF; Arafah BM; Ladenson PW; Pinchera A
J Clin Endocrinol Metab; 2003 Apr; 88(4):1433-41. PubMed ID: 12679418
[TBL] [Abstract][Full Text] [Related]
37. [The significance of thyroglobulin determination in the follow-up of patients with papillary or follicular thyroid carcinoma].
Hennemann G; Hennemann IP; Docter R; Krenning EP
Ned Tijdschr Geneeskd; 1989 Mar; 133(10):491-3. PubMed ID: 2651932
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
